AMICOSANTE, Gianfranco
 Distribuzione geografica
Continente #
NA - Nord America 12.220
AS - Asia 6.991
EU - Europa 6.323
SA - Sud America 878
AF - Africa 104
Continente sconosciuto - Info sul continente non disponibili 23
OC - Oceania 16
Totale 26.555
Nazione #
US - Stati Uniti d'America 12.070
SG - Singapore 2.845
CN - Cina 1.505
IE - Irlanda 1.464
RU - Federazione Russa 1.198
TR - Turchia 889
BR - Brasile 767
DE - Germania 767
HK - Hong Kong 700
IT - Italia 545
GB - Regno Unito 521
VN - Vietnam 521
UA - Ucraina 438
SE - Svezia 419
FR - Francia 383
FI - Finlandia 290
IN - India 133
BD - Bangladesh 79
NL - Olanda 79
JP - Giappone 75
CA - Canada 66
MX - Messico 52
BE - Belgio 44
ES - Italia 38
PL - Polonia 38
IQ - Iraq 37
AR - Argentina 36
ZA - Sudafrica 36
ID - Indonesia 34
KR - Corea 22
EU - Europa 20
MA - Marocco 19
EC - Ecuador 18
UZ - Uzbekistan 18
CO - Colombia 17
LT - Lituania 17
PK - Pakistan 17
VE - Venezuela 16
CZ - Repubblica Ceca 15
RO - Romania 15
SA - Arabia Saudita 15
AU - Australia 12
NP - Nepal 10
CH - Svizzera 9
DZ - Algeria 9
IL - Israele 9
JM - Giamaica 9
TN - Tunisia 9
AE - Emirati Arabi Uniti 8
DK - Danimarca 8
JO - Giordania 8
KE - Kenya 8
MY - Malesia 8
PY - Paraguay 8
BO - Bolivia 7
EG - Egitto 7
KG - Kirghizistan 7
OM - Oman 7
PH - Filippine 7
IR - Iran 6
MD - Moldavia 6
AT - Austria 5
GT - Guatemala 5
HU - Ungheria 5
TW - Taiwan 5
AL - Albania 4
CL - Cile 4
HN - Honduras 4
KZ - Kazakistan 4
PE - Perù 4
TH - Thailandia 4
AO - Angola 3
AZ - Azerbaigian 3
DO - Repubblica Dominicana 3
GR - Grecia 3
LB - Libano 3
PA - Panama 3
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
BH - Bahrain 2
CR - Costa Rica 2
GA - Gabon 2
KW - Kuwait 2
MK - Macedonia 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BN - Brunei Darussalam 1
CG - Congo 1
CI - Costa d'Avorio 1
CY - Cipro 1
ET - Etiopia 1
GH - Ghana 1
GN - Guinea 1
GY - Guiana 1
HT - Haiti 1
Totale 26.538
Città #
Jacksonville 1.717
Singapore 1.627
Dublin 1.464
Chandler 1.463
Dallas 1.232
San Jose 1.050
Hong Kong 688
Ashburn 656
Santa Clara 583
Boardman 503
Izmir 489
The Dalles 391
Nanjing 313
Ann Arbor 284
Wilmington 248
Lawrence 228
Princeton 228
New York 224
Moscow 217
Council Bluffs 211
Seattle 187
Beijing 181
Ho Chi Minh City 163
Lauterbourg 159
Columbus 154
San Mateo 127
Hanoi 125
Milan 125
Nanchang 117
Los Angeles 109
Munich 83
Woodbridge 82
L'aquila 76
Mountain View 76
Bremen 74
Tokyo 72
São Paulo 71
Tianjin 65
Shenyang 63
Hebei 57
Düsseldorf 53
Verona 53
Kunming 47
Jiaxing 44
Jinan 44
Brussels 42
Turku 42
Dong Ket 41
Helsinki 40
Hefei 39
Orem 38
Rome 38
Des Moines 36
Frankfurt am Main 36
Dearborn 34
Warsaw 34
Denver 32
Shanghai 32
Fremont 31
Houston 31
Norwalk 31
Rio de Janeiro 31
Changsha 30
Atlanta 27
Chennai 27
Falls Church 27
Jakarta 27
San Francisco 27
Zhengzhou 27
Amsterdam 25
Belo Horizonte 25
Chicago 25
Da Nang 24
Lanzhou 24
Brooklyn 23
Brasília 22
Guangzhou 21
Johannesburg 21
Montreal 21
Ningbo 21
Seoul 21
L’Aquila 19
Stockholm 18
Falkenstein 17
Haiphong 17
London 17
Mexico City 17
Phoenix 17
Poplar 17
Toronto 17
Tashkent 16
Baghdad 15
Changchun 15
Manchester 14
Istanbul 13
Ankara 12
Nuremberg 12
Pelotas 12
Philadelphia 12
Dhaka 11
Totale 17.584
Nome #
OXA-23 Carbapenemase in Multidrug-Resistant Acinetobacter baumannii ST2 Type: First Identification in L'Aquila Hospital (Italy) 194
SOS response in bacteria: Inhibitory activity of lichen secondary metabolites against Escherichia coli RecA protein 190
Ceftibuten stability to active-site serine and metallo-ß-lactamases 181
Influence of L-carnitine on CD95 cross-linking-induced apoptosis and ceramide generation in human cell lines: Correlation with its effects on purified acidic and neutral sphingomyelinases in vitro 176
CTX and its desacetyl derivative (des-CTX): Interaction with some representative β-lactamases and their related pattern of resistance to newer selected clinical isolates 172
Broad spectrum β-lactamases of citrobacter diversus 172
Evaluations of the effects of extremely low-frequency electromagnetic fields on growth and antibiotic susceptibility of escherichia coli and pseudomonas aeruginosa 172
Ceftaroline in vitro activity against methicillin-resistant Staphylococcus aureus and coagulase-negative Staphylococci: a short report from Italy 171
In vitro interaction of usnic acid in combination with antimicrobial agents against methicillin-resistant Staphylococcus aureus clinical isolates determined by FICI and Delta E model methods 170
The 1.5-Å structure of Chryseobacterium meningosepticum zinc β-lactamase in complex with the inhibitor, D-captopril 169
A class-A β-lactamase from Pseudomonas stutzeri that is highly active against monobactams and cefotaxime 167
Inhibition of the transcriptional repressor LexA: Withstanding drug resistance by inhibiting the bacterial mechanisms of adaptation to antimicrobials 166
First Identification of β-Lactamases in Antibiotic-Resistant Escherichia coli, Citrobacter freundii, and Aeromonas spp. Isolated in Stream Macroinvertebrates in a Central Italian Region. 165
Cyclic and acyclic amine oxide alkyl derivatives as potential adjuvants in antimicrobial chemotherapy against methicillin-resistant staphylococcus aureus with an MDR profile 165
Characterization of a β-lactamase produced in Mycobacterium fortuitum D316 161
Anti-apoptotic and anti-inflammatory activity of Gentiana lutea root extract 161
Cloning and nucleotide sequencing of the gene encoding the ß-lactamase from Citrobacter diversus 159
Interaction between antimicrobial peptides (AMPs) and their primary target, the biomembranes 159
Bovine lactoferrin and its tryptic peptides: Antibacterial activity against different species 159
Transient disappearance of CD19+/CD5+ B-lymphocyte clone in peripheral blood in a patient with CLL during SARS-CoV-2-related mild disease 159
Identification of bla(IMP-22) in Pseudomonas spp. in urban wastewater and nosocomial environments: biochemical characterization of a new IMP metallo-enzyme variant and its genetic location 157
In vitro antimicrobial activity of pannarin alone and in combination with antibiotics against methicillin-resistant Staphylococcus aureus clinical isolates 157
Antimicrobial susceptibility of clinical isolates of Enterobacteriaceae producing complex β-lactamase patterns including extended-spectrum enzymes 156
β-lactamase of Mycobacterium fortuitum: Kinetics of production and relationship with resistance to β-lactam antibiotics 154
Kinetic Study of the Effect of Histidines 240 and 164 on TEM-149 Enzyme Probed by β-Lactam Inhibitors. 151
Beta-lactamase of Mycobacterium fortuitum: Introduction to the problem and first experimental data on purification and characterization 151
Cloning and characterization of bla(VIM), a new integron-borne metallo- β-lactamase gene from a Pseudomonas aeruginosa clinical isolate 151
Cytotoxic activity and antioxidant capacity of purified lichen metabolites: an in vitro study 149
β-Lactamases as major mechanism of resi stance in Gram-negative bacteria. 149
E240V substitution increases catalytic efficiency toward ceftazidime in a new natural TEM-type extended-spectrum beta-lactamase, TEM-149, from Enterobacter aerogenes and Serratia marcescens clinical isolates 149
Replacement R164H and V240H by site-directed mutagenesis of TEM-149 ESBL: kinetic analysis of TEM-149H240 and TEM-149H164-H240 laboratory mutants 148
Inhibitory Potential of Polyclonal Camel Antibodies against New Delhi Metallo-β-lactamase-1 (NDM-1). 147
Lactobacillus sakei pro-bio65 reduces tnf-α expression and upregulates gsh content and antioxidant enzymatic activities in human conjunctival cells 147
Emergence of blaKPC-3-Tn4401a in Klebsiella pneumoniae ST512 in the municipal wastewater treatment plant and in the university hospital of a town in central Italy. 146
Protolichesterinic acid enhances doxorubicin-induced apoptosis in HeLa cells in vitro 146
Kinetic studies on CphA mutants reveal the role of the P158-P172 loop in activity versus carbapenems 146
Amino acid replacement at position 228 induces fluctuation in the Ω-loop of KPC-3 and reduces the affinity against oxyimino cephalosporins: Kinetic and molecular dynamics studies 146
Interaction of neomycin with human erythrocytes 145
CTX-M-type extended-spectrum β-lactamases in Italy: Molecular epidemiology of an emerging countrywide problem 145
Interactions of biapenem with active-site serine and metallo-β-lactamases 145
Extremely low frequency (ELF) electromagnetic field (EMF) reduces quercetin-induced apoptosis in K562 cells: possible role of HSP-70 145
QnrB9 in association with TEM-116 extended-spectrum beta-lactamase in Citrobacter freundii isolated from sewage effluent: first report from Italy 144
Use of chromatofocusing in purification of proteins 143
Interaction of carbapenems and β-lactamase inhibitors towards CTX-M-15 and CTX-M-15G238Cmutant 143
Transcription and expression analysis, using lacZ and phoA gene fusions, of Mycobacterium fortuitum β-lactamase genes cloned from a natural isolate and a high-level β-lactamase producer 142
Derivative spectroscopy as a nonperturbative tool to detect the state of liposome-entrapped sulbactam 142
Exploring the role of l10 loop in new delhi metallo-β-lactamase (Ndm-1): Kinetic and dynamic studies 142
Characterization of a new extended-spectrum β-lactamase (TEM-87) isolated in Proteus mirabilis during an Italian survey 141
Rapid characterization and partial purification of various animal amine oxidases 140
In vitro selection and characterization of mutants in TEM-1-producing Escherichia coli by ceftazidime and ceftibuten 140
Characterization of a new TEM-derived β-lactamase produced in a Serratia marcescens strain 139
Citrobacter diversus ULA27 produces two forms of a chromosomal β-lactamase 139
Prevalence and characterization of metallo-β-lactamases in clinical isolates of Pseudomonas aeruginosa 139
Potent inhibitory activity of taniborbactam towards NDM-1 and NDM-1Q119X mutants, and in vitro activity of cefepime/taniborbactam against MBLs producing Enterobacterales 139
Identification of new natural CphA metallo-β-lactamases CphA4 and CphA5 in Aeromonas veronii and Aeromonas hydrophila Isolates from municipal sewage in central Italy 138
In vitro activity of cefodizime (HR-221) in combination with β-lactamase inhibitors 138
Kinetic profile and molecular dynamic studies show that Y229W substitution in an NDM-1/L209F variant restores the hydrolytic activity of the enzyme toward penicillins, cephalosporins, and carbapenems 138
BlaB-15, a new BlaB metallo-β-lactamase variant found in an Elizabethkingia miricola clinical isolate 136
Spread of blaCTX-M-type and blaPER-2 β-lactamase genes in clinical isolates from Bolivian hospitals 136
Exploring the role of L209 residue in the active site of NDM-1 a metallo-β-lactamase 136
High specificity of cphA-encoded metallo-β-lactamase from Aeromonas hydrophila AE036 for carbapenems and its contribution to β-lactam resistance 135
Overexpression system and biochemical profile of CTX-M-3 extended-spectrum β-lactamase expressed in Escherichia coli 134
Fractionation and characterization of two β-lactamases in Citrobacter diversus ULA-27 strain by chromatofocusing 134
P174E substitution in GES-1 and GES-5 β-lactamases improves catalytic efficiency towards carbapenems. 134
Effects of extracts from lactic acid bacteria on tumor cell invasiveness in vitro 132
Meropenem stability to β-lactamase hydrolysis and comparative in vitro activity against several β-lactamase-producing Gram-negative strains 132
Dynamical aspects of TEM-1 β-Lactamase probed by molecular dynamics 132
Molecular characterization of carbapenem-resistant Klebsiella pneumoniae ST14 and ST512 causing bloodstream infections in ICU and surgery wards of a tertiary University hospital of Verona (Northern Italy): co-production of KPC-3, OXA-48, and CTX-M-15 β-lactamases. 132
Ceftazidime and aztreonam resistance in Providencia stuartii: Characterization of a natural TEM-derived extended-spectrum β-lactamase, TEM-60 131
Apoptotic effects of selected strains of lactic acid bacteria on a human T leukemia cell line are associated with bacterial arginine deiminase and/or sphingomyelinase activities 130
Encapsulation of ampicillin in reverse-phase evaporation liposomes: a direct evaluation by derivative spectrophotometry 130
Interaction between lichen secondary metabolites and antibiotics against clinical isolates methicillin-resistant staphylococcus aureus strains. 129
Curcumin inhibits the SOS response induced by levofloxacin in Escherichia coli 129
Novel TEM-type extended-spectrum β-lactamase, TEM-134, in a Citrobacter koseri clinical isolate 129
In vitro Activity of Cefiderocol and Comparator Agents tested against Carbapenem-Resistant Acinetobacter baumannii (CRAb) from six Italian laboratories. 128
A new metallo-beta-lactamase gene (blaIMP-22) harboured in class 1 integron from Pseudomonas fluorescens 128
Kinetic study of laboratory mutants of NDM-1 metallo-β-lactamase and the importance of an isoleucine at position 35 128
Protocetraric and Salazinic Acids as Potential Inhibitors of SARS-CoV-2 3CL Protease: Biochemical, Cytotoxic, and Computational Characterization of Depsidones as Slow-Binding Inactivators 128
A Two Amino Acid Duplication, L167E168, in the X-Loop Drastically Decreases Carbapenemase Activity of KPC-53, a Natural Class A β-Lactamase 127
Biochemical characterization of TEM-92 extended-spectrum β-lactamase, a protein differing from TEM-52 in the signal peptide 127
Laboratory variants GESG170L, GESG170K, and GESG170H increase carbapenem hydrolysis and confer resistance to clavulanic acid 127
Biochemical analysis of TEM-134, a new TEM-type extended-spectrum beta-lactamase variant produced in a Citrobacter koseri clinical isolate from an Italian hospital 126
Leucocianidine e collagenasi: inibizione dell’attività enzimatica “in vitro” 126
Characterization of the chromosomal cephalosporinases produced by Acinetobacter Iwoffii and Acinetobacter baumannii clinical isolates 126
β-Lactamase induction antagonizes β-lactam susceptibilities in Citrobacter diversus and Enterobacter cloacae clinical isolates 126
In vitro selected fluoroquinolone-resistant mutants of Citrobacter freundii: Analysis of the quinolone resistance acquisition 125
Dynamics of a nosocomial outbreak of multidrug-resistant Pseudomonas aeruginosa producing the PER-1 extended-spectrum β-lactamase 125
Presence of the ica operon in clinical isolates of Staphylococcus epidermidis and its role in biofilm production 124
Natural D240G Toho1 mutant conferring resistance to ceftazidime: biochemical characterization of CTX-M-43 124
Effect of V88L, M154L and A233V amino acid substitutions on NDM-1 metallo-β-lactamase: kinetic and dynamic studies. 123
Use of the chromosomal class A β-lactamase of Mycobacterium fortuitum D316 to study potentially poor substrates and inhibitory β-lactam compounds 123
Resistome and Virulome of Multi-Drug Resistant E. coli ST131 Isolated from Residents of Long-Term Care Facilities in the Northern Italian Region 123
Photohemolysis of erythrocytes enriched with superoxide dismutase, catalase and glutathione peroxidase 122
Bactericidal activity of levofloxacin and ciprofloxacin on clinical isolates of different phenotypes of Pseudomonas aeruginosa 121
Sensitivity of Aeromonas hydrophila carbapenemase to δ3-cephems: Comparative study with other metallo-β-lactamases 121
On the kinetic interaction between ceftriaxone and some β-lactamases 121
Proteolytic interconversion and N-terminal sequences of the Citrobacter diversus major β-lactamases 121
Antibacterial activity of selected metabolites from Chilean lichen species against methicillin-resistant staphylococci 121
Decreased production of AmpC-type β-lactamases associated with the development of resistance to quinolones in Citrobacter freundii strains 120
Nimesulide e Collagenasi: inibizione dell'attività enzimatica "in vitro" 119
Totale 14.246
Categoria #
all - tutte 110.165
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 110.165


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202184 0 0 0 0 0 0 0 0 0 0 0 84
2021/20221.507 55 70 149 68 61 29 42 308 82 65 92 486
2022/20234.293 314 245 56 463 457 406 2 260 1.899 21 108 62
2023/2024867 143 69 77 91 72 213 21 69 8 25 25 54
2024/20254.856 89 69 415 256 743 483 670 466 876 178 422 189
2025/20268.566 441 890 969 958 902 725 1.376 299 686 780 387 153
Totale 27.369